How are you all doing?! Schlesinger Group is looking for those who are taking a cholesterol-lowering drug that belong to the same class known as PCSK9 inhibitors (such as Praluent and/or Repatha) to participate in an online study with us. This study will be taking place from February 1st – February 6th.
If qualified and asked to participate, you will be paid for your time and opinions.
If you’re interested please fill out the short questionnaire below to see if you qualify: